UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000012942 |
|---|---|
| Receipt number | R000015119 |
| Scientific Title | Open Label Phase I Trial of intramyocardial AMG0001-01 administration in chronic heart failure patients with ischemic cardiomyopathy |
| Date of disclosure of the study information | 2014/07/01 |
| Last modified on | 2016/07/27 10:29:50 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Open Label Phase I Trial of
intramyocardial AMG0001-01
administration in chronic heart
failure patients with
ischemic cardiomyopathy
Acronym
Clinical Trial of intramyocardial
AMG0001-01 administration in
chronic heart failure patients
Scientific Title
Open Label Phase I Trial of
intramyocardial AMG0001-01
administration in chronic heart
failure patients with
ischemic cardiomyopathy
Scientific Title:Acronym
Clinical Trial of intramyocardial
AMG0001-01 administration in
chronic heart failure patients
Region
| Japan |
Condition
Condition
chronic heart failure
Classification by specialty
| Vascular surgery |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
Evaluation of safety and tolerability
Basic objectives2
Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
frequency of adverse event
incidence for adverse event
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Treatment
Type of intervention
| Medicine |
Interventions/Control_1
10-spot administration of 0.4mg/0.2mL/site
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 85 | years-old | > |
Gender
Male and Female
Key inclusion criteria
ischemic cardiomyopathy
NYHA functional Class iii or iv
LVEF<=40%
Key exclusion criteria
patient implanted with an LVAD
thickness of left ventricular wall<5mm
severe pulmonary hypertension
Target sample size
3
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Yoshiki sawa |
Organization
osaka university hospital
Division name
Cardiovascular surgery
Zip code
Address
2-15 Yamadaoka Suita,Osaka
TEL
06-6879-3154
sawa@surg1.med.osaka-u.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Shigeru miyagawa |
Organization
osaka university hospital
Division name
Cardiovascular surgery
Zip code
Address
2-15 Yamadaoka Suita,Osaka
TEL
06-6879-3154
Homepage URL
miyagawa@surg1.med.osaka-u.ac.jp
Sponsor or person
Institute
osaka university hospital
Institute
Department
Personal name
Funding Source
Organization
AnGes MG
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
JAPAN
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2014 | Year | 07 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Terminated
Date of protocol fixation
| 2014 | Year | 07 | Month | 01 | Day |
Date of IRB
Anticipated trial start date
| 2014 | Year | 10 | Month | 01 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2014 | Year | 01 | Month | 24 | Day |
Last modified on
| 2016 | Year | 07 | Month | 27 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015119
